No association of endothelial lipase and aldose reductase polymorphisms with proliferative diabetic retinopathy: Results of the French prospective multicenter REDIAGEN study

Affiliations

• ¹ Department of Ophthalmology, Reims University Hospital, Reims, France; RétiNantes, Institut Ophtalmologique de l'Ouest, Clinique Jules Verne, Nantes, France.
• ² Department of Ophthalmology, Reims University Hospital, Reims, France.
• ³ Department of Methodology, Reims University Hospital, Reims, France.
• ⁴ Department of Biochemistry, Pharmacology and Toxicology, Reims University Hospital, Reims 51092, France.
• ⁵ Cardio-Thoracic Department, Reims University Hospital, Reims, France.
• ⁶ Biopathology Department, Reims University Hospital, Reims, France.
• ⁷ Department of Ophthalmology, Nancy University Hospital, Nancy, France.
• ⁸ Department of Ophthalmology, Dijon University Hospital, Dijon, France.
• ⁹ Department of Ophthalmology, Colmar Hospital, Colmar, France.
• ¹⁰ Department of Ophthalmology, Strasbourg University Hospital, Strasbourg, France.
• ¹¹ Department of Endocrinology, Diabetology, and Nutrition, Brabois Adult Hospital, Vandoeuvre-lès-Nancy, France.
• ¹² Department of Ophthalmology, Mulhouse Sud Alsace Regional Hospital Group, Mulhouse, France.
• ¹³ Department of Ophthalmology, Amiens University Hospital, Amiens, France.
• ¹⁴ Department of Ophthalmology, Metz-Thionville Regional Hospital Center, Metz, France.
• ¹⁵ CNRS UMR 7369, « Matrice Extracellulaire et Dynamique Cellulaire » (MEDyC), Reims University, Reims, France. Electronic address: vdurlach@chu-reims.fr.